Research
Energy balance
Emerging clinical trials support the potential of GLP-1 receptor agonists in reversing cancer risk.
Practitioners should stay updated on clinical trial results regarding GLP-1 agonists and cancer risk.
StrongSupportsmedium confidence
emerging clinical trials support this so far.
Why this rating
Based on the mention of emerging clinical trials.
Source
Will GLP-1 Agonists Weaken the Links between Obesity and Cancer?
Donal J. Brennan et al. · Cancer Discovery · 2025
DOI 10.1158/2159-8290.cd-25-0991
reviewCited 1×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →